Zogenix is committed to developing and commercializing therapies for central nervous system disorders that address specific clinical needs for people living with orphan diseases and other CNS disorders who need innovative treatment alternatives to improve their daily functioning. We seek best-in-class leaders with scientific, medical and commercial expertise in the therapeutic areas in which we participate. By sharing a collective passion for making a difference in the lives of patients we serve, our unique company culture thrives through the principles of ethical decision making, open communication and collaboration. Zogenix was founded in 2006 and has offices in California and the United Kingdom. Zogenix International, Ltd. is a wholly owned subsidiary of Zogenix.
Emeryville, US
Size (employees)
67 (est)+9%
Zogenix was founded in 2006 and is headquartered in Emeryville, US

Zogenix Office Locations

Zogenix has offices in Emeryville, San Diego, Maidenhead
Emeryville, US
Maidenhead, GB
San Diego, US

Zogenix Metrics

Zogenix Summary

Market capitalization

$265.5 m

Closing share price

Zogenix's current market capitalization is $265.5 m.

Zogenix Financials

Zogenix's revenue is $27.2 m in FY, 2015 which is a 32.9% decrease from the previous period.
FY, 2013FY, 2014FY, 2015


$33 m$40.5 m$27.2 m

Revenue growth, %


Net Income

($80.9 m)$8.6 m$26.1 m

Zogenix Market Value History

Zogenix Online Presence

Zogenix Company Life

You may also be interested in